Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2010 | Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer | JIH-HSIANG LEE ; CHONG-JEN YU ; KUAN-YU CHEN ; JIN-YUAN SHIH ; Lin Y.-L.; CHIH-HSIN YANG | Journal of the Formosan Medical Association | 6 | 5 | |
2012 | Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation | Lu C.-H.; Hsiao C.-H.; YEUN-CHUNG CHANG ; JANG-MING LEE ; JIN-YUAN SHIH ; Wu L.-A.; CHONG-JEN YU ; HON-MAN LIU ; TIFFANY TING-FANG SHIH ; PAN-CHYR YANG | Journal of Thoracic Oncology | 62 | 59 | |
2011 | Pericardial pigtail knotting | SHANG-GIN WU ; JIN-YUAN SHIH | European Journal of Cardio-thoracic Surgery | 3 | 3 | |
2013 | Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas | Wu P.-F.; Huang W.-C.; CHIH-HSIN YANG ; YEN-SHEN LU ; JIN-YUAN SHIH ; SHANG-GIN WU ; CHING-HUNG LIN ; ANN-LII CHENG | Journal of Neuro-Oncology | 8 | 5 | |
2008 | Pleurocutaneous fistula after tube thoracostomy: Sonographic findings | Lin M.-T.; JIN-YUAN SHIH ; Lee Y.-C.; PAN-CHYR YANG | Journal of Clinical Ultrasound | 11 | 11 | |
2010 | Potential roles of fibroblast growth factor-9 in the benzo(a)pyrene-induced invasion in vitro and the metastasis of human lung adenocarcinoma | YIH-LEONG CHANG ; Tsai Y.-Y.; Su J.-L.; Chan P.-K.; JIN-YUAN SHIH ; Lee Y.-C.; Ma Y.-C.; Kuo M.-L. | Archives of Toxicology | 29 | 27 | |
2006 | Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients | Chang G.-C.; Tsai C.-M.; Chen K.-C.; CHONG-JEN YU ; JIN-YUAN SHIH ; Yang T.-Y.; Lin C.-P.; Hsu J.-Y.; Chiu C.-H.; Perng R.-P.; PAN-CHYR YANG ; CHIH-HSIN YANG | Journal of Thoracic Oncology | 44 | 35 | |
2008 | Predictors of toxicity of weekly docetaxel in chemotherapy-treated non-small cell lung cancers | JO-PAI CHEN ; Lo Y.; CHONG-JEN YU ; CHIUN HSU ; JIN-YUAN SHIH ; CHIH-HSIN YANG | Lung Cancer | 12 | 7 | |
2012 | Pretreatment Epidermal Growth Factor Receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer | KANG-YI SU ; Chen H.-Y.; Li K.-C.; Kuo M.-L.; CHIH-HSIN YANG ; Chan W.-K.; Ho B.-C.; Chang G.-C.; JIN-YUAN SHIH ; SUNG-LIANG YU ; PAN-CHYR YANG | Journal of Clinical Oncology | 464 | 428 | |
2008 | Primary mediastinal large B-cell lymphoma mimicking liposarcoma | CHUN-TA HUANG ; Huang W.C.; JIN-YUAN SHIH ; PAN-CHYR YANG | Medical Oncology | 0 | 0 | |
1998 | Primary pulmonary plasmacytoma with lobar consolidation: An unusual presentation | KUAN-YU CHEN ; Wu H.-D.; YIH-LEONG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 12 | 8 | |
2020 | Primary resistance to osimertinib despite acquired T790M | Chang L.-K.; YIH-LEONG CHANG ; JIN-YUAN SHIH | Respirology Case Reports | 3 | 2 | |
2005 | Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes | Sher Y.-P.; JIN-YUAN SHIH ; PAN-CHYR YANG ; Roffler S.R.; Chu Y.-W.; Wu C.-W.; CHIA-LI YU ; Peck K. | Clinical Cancer Research | 102 | 91 | |
2021 | Prognostic Characteristics and Immunotherapy Response of Patients With Nonsquamous NSCLC With Kras Mutation in East Asian Populations: A Single-Center Cohort Study in Taiwan | SHANG-GIN WU ; WEI-YU LIAO ; KANG-YI SU ; SUNG-LIANG YU ; YEN-LIN HUANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; JIN-YUAN SHIH | JTO Clinical and Research Reports | 16 | 0 | |
2018 | Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study | SHENG-KAI LIANG ; MENG-RUI LEE ; WEI-YU LIAO ; CHAO-CHI HO ; JEN-CHUNG KO ; JIN-YUAN SHIH | Oncotarget | 17 | 0 | |
2011 | The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma | YAO-WEN KUO ; JIH-SHUIN JERNG ; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHONG-JEN YU ; PAN-CHYR YANG | Journal of Thoracic Oncology | 26 | 24 | |
2022 | Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Inhibitors in NSCLC: Two Heads Are Better Than One | YEN-TING LIN ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 0 | 0 | |
2001 | Pulmonary pleomorphic (spindle) cell carcinoma: Peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma | YIH-LEONG CHANG ; Lee Y.-C.; JIN-YUAN SHIH ; CHEN-TU WU | Lung Cancer | 174 | 135 | |
2008 | Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response | Gow C.-H.; Chien C.-R.; YIH-LEONG CHANG ; Chiu Y.-H.; SUNG-HSIN KUO ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG | Clinical Cancer Research | 132 | 125 | |
2020 | Ramucirumab or placebo plus erlotinib in EGFR-mutated, metastatic non-small-cell lung cancer: East Asian subset of RELAY | Nishio M.; Seto T.; Reck M.; Garon E.B.; Chiu C.-H.; Yoh K.; Imamura F.; Park K.; JIN-YUAN SHIH ; Visseren-Grul C.; Frimodt-Moller B.; Zimmermann A.; Homma G.; Enatsu S.; Nakagawa K.; RELAY Study Investigators | Cancer science | 17 | 12 |